1. Academic Validation
  2. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation

Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation

  • J Biol Chem. 2006 Jul 7;281(27):18370-7. doi: 10.1074/jbc.M602469200.
Kentaro Kato 1 Charlotte Jeanneau Mads Agervig Tarp Anna Benet-Pagès Bettina Lorenz-Depiereux Eric Paul Bennett Ulla Mandel Tim M Strom Henrik Clausen
Affiliations

Affiliation

  • 1 Department of Medical Biochemistry and Genetics, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.
Abstract

Mutations in the gene encoding the Glycosyltransferase polypeptide GalNAc-T3, which is involved in initiation of O-glycosylation, were recently identified as a cause of the rare autosomal recessive metabolic disorder familial tumoral calcinosis (OMIM 211900). Familial tumoral calcinosis is associated with hyperphosphatemia and massive ectopic calcifications. Here, we demonstrate that the secretion of the phosphaturic factor Fibroblast Growth Factor 23 (FGF23) requires O-glycosylation, and that GalNAc-T3 selectively directs O-glycosylation in a subtilisin-like proprotein convertase recognition sequence motif, which blocks processing of FGF23. The study suggests a novel posttranslational regulatory model of FGF23 involving competing O-glycosylation and Protease processing to produce intact FGF23.

Figures